Global Colorectal Cancer Diagnostics & Therapeutics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Colorectal Cancer Diagnostics
  • 1.2.3 Colorectal Cancer Therapeutics
• 1.3 Market by Application
  • 1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Specialty Clinics
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2017-2028)
• 2.2 Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Region
  • 2.2.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Region (2017-2022)
  • 2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2023-2028)
• 2.3 Colorectal Cancer Diagnostics & Therapeutics Market Dynamics
  • 2.3.1 Colorectal Cancer Diagnostics & Therapeutics Industry Trends
  • 2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
  • 2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
  • 2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue
  • 3.1.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue (2017-2022)
  • 3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2017-2022)
• 3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics & Therapeutics Revenue
• 3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
  • 3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2021
• 3.5 Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Area Served
• 3.6 Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
• 3.7 Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type

• 4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2017-2022)
• 4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2023-2028)

5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application

• 5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2017-2022)
• 5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
• 6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
  • 6.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
  • 6.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
  • 6.2.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
• 6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
  • 6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
  • 6.3.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
  • 6.3.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
• 6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
  • 6.4.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
  • 6.4.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
• 7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
  • 7.2.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
  • 7.2.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
  • 7.2.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
• 7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
  • 7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
  • 7.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
  • 7.3.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
• 7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
  • 7.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
  • 7.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
• 8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
  • 8.2.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
  • 8.3.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region
  • 8.4.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
• 9.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
  • 9.2.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
  • 9.2.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
  • 9.2.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
• 9.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
  • 9.3.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
  • 9.3.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
  • 9.3.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
• 9.4 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
  • 9.4.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
  • 9.4.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
• 10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
  • 10.2.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
  • 10.3.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
  • 10.4.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Biocept
  • 11.1.1 Biocept Company Details
  • 11.1.2 Biocept Business Overview
  • 11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.1.5 Biocept Recent Developments
• 11.2 Cancer Genetics
  • 11.2.1 Cancer Genetics Company Details
  • 11.2.2 Cancer Genetics Business Overview
  • 11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.2.5 Cancer Genetics Recent Developments
• 11.3 Foundation Medicine
  • 11.3.1 Foundation Medicine Company Details
  • 11.3.2 Foundation Medicine Business Overview
  • 11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.3.5 Foundation Medicine Recent Developments
• 11.4 Sysmex Corporation
  • 11.4.1 Sysmex Corporation Company Details
  • 11.4.2 Sysmex Corporation Business Overview
  • 11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.4.5 Sysmex Corporation Recent Developments
• 11.5 Danaher Corporation
  • 11.5.1 Danaher Corporation Company Details
  • 11.5.2 Danaher Corporation Business Overview
  • 11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.5.5 Danaher Corporation Recent Developments
• 11.6 Epigenomics
  • 11.6.1 Epigenomics Company Details
  • 11.6.2 Epigenomics Business Overview
  • 11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.6.5 Epigenomics Recent Developments
• 11.7 Illumina
  • 11.7.1 Illumina Company Details
  • 11.7.2 Illumina Business Overview
  • 11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.7.5 Illumina Recent Developments
• 11.8 Rosetta Genomics
  • 11.8.1 Rosetta Genomics Company Details
  • 11.8.2 Rosetta Genomics Business Overview
  • 11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.8.5 Rosetta Genomics Recent Developments
• 11.9 Exact Science Corporation
  • 11.9.1 Exact Science Corporation Company Details
  • 11.9.2 Exact Science Corporation Business Overview
  • 11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.9.5 Exact Science Corporation Recent Developments
• 11.10 Pathway Genomics Corporation
  • 11.10.1 Pathway Genomics Corporation Company Details
  • 11.10.2 Pathway Genomics Corporation Business Overview
  • 11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.10.5 Pathway Genomics Corporation Recent Developments
• 11.11 Taiho Pharma
  • 11.11.1 Taiho Pharma Company Details
  • 11.11.2 Taiho Pharma Business Overview
  • 11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.11.5 Taiho Pharma Recent Developments
• 11.12 Merck KGaA
  • 11.12.1 Merck KGaA Company Details
  • 11.12.2 Merck KGaA Business Overview
  • 11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.12.5 Merck KGaA Recent Developments
• 11.13 Amgen
  • 11.13.1 Amgen Company Details
  • 11.13.2 Amgen Business Overview
  • 11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.13.5 Amgen Recent Developments
• 11.14 Takeda
  • 11.14.1 Takeda Company Details
  • 11.14.2 Takeda Business Overview
  • 11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.14.5 Takeda Recent Developments
• 11.15 Roche
  • 11.15.1 Roche Company Details
  • 11.15.2 Roche Business Overview
  • 11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.15.5 Roche Recent Developments
• 11.16 Eli Lilly
  • 11.16.1 Eli Lilly Company Details
  • 11.16.2 Eli Lilly Business Overview
  • 11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.16.5 Eli Lilly Recent Developments
• 11.17 Sanofi
  • 11.17.1 Sanofi Company Details
  • 11.17.2 Sanofi Business Overview
  • 11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.17.5 Sanofi Recent Developments
• 11.18 Regeneron
  • 11.18.1 Regeneron Company Details
  • 11.18.2 Regeneron Business Overview
  • 11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.18.5 Regeneron Recent Developments
• 11.19 Bayer
  • 11.19.1 Bayer Company Details
  • 11.19.2 Bayer Business Overview
  • 11.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.19.4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.19.5 Bayer Recent Developments
• 11.20 Onyx
  • 11.20.1 Onyx Company Details
  • 11.20.2 Onyx Business Overview
  • 11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
  • 11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
  • 11.20.5 Onyx Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Colorectal Cancer Diagnostics
• Table 3. Key Players of Colorectal Cancer Therapeutics
• Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2017-2022)
• Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2023-2028)
• Table 10. Colorectal Cancer Diagnostics & Therapeutics Market Trends
• Table 11. Colorectal Cancer Diagnostics & Therapeutics Market Drivers
• Table 12. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
• Table 13. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
• Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Players (2017-2022)
• Table 16. Global Top Colorectal Cancer Diagnostics & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2021)
• Table 17. Ranking of Global Top Colorectal Cancer Diagnostics & Therapeutics Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
• Table 21. Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2017-2022)
• Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2023-2028)
• Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Application (2017-2022)
• Table 29. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Application (2023-2028)
• Table 31. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Biocept Company Details
• Table 62. Biocept Business Overview
• Table 63. Biocept Colorectal Cancer Diagnostics & Therapeutics Product
• Table 64. Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 65. Biocept Recent Developments
• Table 66. Cancer Genetics Company Details
• Table 67. Cancer Genetics Business Overview
• Table 68. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product
• Table 69. Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 70. Cancer Genetics Recent Developments
• Table 71. Foundation Medicine Company Details
• Table 72. Foundation Medicine Business Overview
• Table 73. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product
• Table 74. Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 75. Foundation Medicine Recent Developments
• Table 76. Sysmex Corporation Company Details
• Table 77. Sysmex Corporation Business Overview
• Table 78. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product
• Table 79. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 80. Sysmex Corporation Recent Developments
• Table 81. Danaher Corporation Company Details
• Table 82. Danaher Corporation Business Overview
• Table 83. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product
• Table 84. Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 85. Danaher Corporation Recent Developments
• Table 86. Epigenomics Company Details
• Table 87. Epigenomics Business Overview
• Table 88. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product
• Table 89. Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 90. Epigenomics Recent Developments
• Table 91. Illumina Company Details
• Table 92. Illumina Business Overview
• Table 93. Illumina Colorectal Cancer Diagnostics & Therapeutics Product
• Table 94. Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 95. Illumina Recent Developments
• Table 96. Rosetta Genomics Company Details
• Table 97. Rosetta Genomics Business Overview
• Table 98. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product
• Table 99. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 100. Rosetta Genomics Recent Developments
• Table 101. Exact Science Corporation Company Details
• Table 102. Exact Science Corporation Business Overview
• Table 103. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product
• Table 104. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 105. Exact Science Corporation Recent Developments
• Table 106. Pathway Genomics Corporation Company Details
• Table 107. Pathway Genomics Corporation Business Overview
• Table 108. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product
• Table 109. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 110. Pathway Genomics Corporation Recent Developments
• Table 111. Taiho Pharma Company Details
• Table 112. Taiho Pharma Business Overview
• Table 113. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product
• Table 114. Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 115. Taiho Pharma Recent Developments
• Table 116. Merck KGaA Company Details
• Table 117. Merck KGaA Business Overview
• Table 118. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product
• Table 119. Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 120. Merck KGaA Recent Developments
• Table 121. Amgen Company Details
• Table 122. Amgen Business Overview
• Table 123. Amgen Colorectal Cancer Diagnostics & Therapeutics Product
• Table 124. Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 125. Amgen Recent Developments
• Table 126. Takeda Company Details
• Table 127. Takeda Business Overview
• Table 128. Takeda Colorectal Cancer Diagnostics & Therapeutics Product
• Table 129. Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 130. Takeda Recent Developments
• Table 131. Roche Company Details
• Table 132. Roche Business Overview
• Table 133. Roche Colorectal Cancer Diagnostics & Therapeutics Product
• Table 134. Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 135. Roche Recent Developments
• Table 136. Eli Lilly Company Details
• Table 137. Eli Lilly Business Overview
• Table 138. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product
• Table 139. Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 140. Eli Lilly Recent Developments
• Table 141. Sanofi Company Details
• Table 142. Sanofi Business Overview
• Table 143. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product
• Table 144. Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 145. Sanofi Recent Developments
• Table 146. Regeneron Company Details
• Table 147. Regeneron Business Overview
• Table 148. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product
• Table 149. Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 150. Regeneron Recent Developments
• Table 151. Bayer Company Details
• Table 152. Bayer Business Overview
• Table 153. Bayer Colorectal Cancer Diagnostics & Therapeutics Product
• Table 154. Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 155. Bayer Recent Developments
• Table 156. Onyx Company Details
• Table 157. Onyx Business Overview
• Table 158. Onyx Colorectal Cancer Diagnostics & Therapeutics Product
• Table 159. Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022) & (US$ Million)
• Table 160. Onyx Recent Developments
• Table 161. Research Programs/Design for This Report
• Table 162. Key Data Information from Secondary Sources
• Table 163. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Type: 2021 VS 2028
• Figure 2. Colorectal Cancer Diagnostics Features
• Figure 3. Colorectal Cancer Therapeutics Features
• Figure 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2021 VS 2028
• Figure 5. Hospitals Case Studies
• Figure 6. Specialty Clinics Case Studies
• Figure 7. Others Case Studies
• Figure 8. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
• Figure 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region: 2021 VS 2028
• Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players in 2021
• Figure 13. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2021)
• Figure 14. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2021
• Figure 15. North America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 16. North America Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 17. North America Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Country (2017-2028)
• Figure 19. United States Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 20. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 22. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 23. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 24. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Country (2017-2028)
• Figure 25. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. France Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 32. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 33. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 34. Asia Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Region (2017-2028)
• Figure 35. China Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. India Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 41. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 42. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 43. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 44. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Country (2017-2028)
• Figure 45. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 48. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 49. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 50. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Country (2017-2028)
• Figure 51. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. UAE Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 55. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 56. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 57. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 58. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 59. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 60. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 61. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 62. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 63. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 64. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 65. Merck KGaA Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 66. Amgen Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 67. Takeda Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 68. Roche Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 69. Eli Lilly Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 70. Sanofi Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 71. Regeneron Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 72. Bayer Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 73. Onyx Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
• Figure 74. Bottom-up and Top-down Approaches for This Report
• Figure 75. Data Triangulation
• Figure 76. Key Executives Interviewed